@Yale_CRIT


Yale_CRIT
@Yale_CRIT -
Dec 10

Read the complaint filed by Yale's @MFIAclinic on behalf of Charles Seife (@CGSeife) and Dr. Peter Lurie (@DrPeterLurie). https://t.co/bRRW6m73E8

Yale_CRIT
@Yale_CRIT -
Dec 10

Patients & researchers have a right to clinical trial results on https://t.co/qp1SHLkPBA, but many results go unreported, so @Yale_CRIT and @MFIAclinic attys sued on behalf of @CGSeife and @DrPeterLurie to ensure NIH and FDA notify the public of unreported trials, as law requires

Yale_CRIT
@Yale_CRIT -
Dec 4

@LizSzabo We mourn the loss of our friend and collaborator, Lisa Schwartz. We always enjoyed working with, and learning from, her (and Steven).The healthcare education and research community lost a true champion for patients, who used research to make clinical care work better for patients

Yale_CRIT
@Yale_CRIT -
Nov 21

Have recent open science initiatives improved the #reproducibility & #transparency of biomed research? According to new study by @Yale_CRIT's @JoshuaDWallach [@YaleSPH @YaleDeptEHS], Boyack, and @METRICStanford's Ioannidis, promising improvements in data, COI, funding statements https://t.co/5giC7WMjfp

Yale_CRIT
@Yale_CRIT -
Nov 7

CRIT Program Mission Statement


To promote health by improving the integrity and transparency of biomedical and clinical research

About the CRIT Program


The Collaboration for Research Integrity and Transparency (CRIT) is an inter-disciplinary initiative launched in 2016 to enhance the quality and transparency of the research base for medical products. Through research, advocacy, and litigation, CRIT is focused on ensuring that the clinical evidence that supports and informs our understanding of the safety and effectiveness of pharmaceuticals, medical devices, and other medical products is accurate, comprehensive, accessible, and reliable. The lack of transparency and integrity in clinical research has had serious consequences for patient and clinicians. Current legal structures and research practices are not adequate and efforts to understand and improve clinical research transparency and reporting are needed.

By influencing stakeholders engaged in the clinical research process and in translating these findings for clinical care, CRIT will focus and magnify the impact of our and others’ scholarship, policy analysis and legal action, advancing the field of research integrity, open science, and informing public discourse.

CRIT aims to

  • Achieve a legal and regulatory environment that promotes rigorous clinical research and supports regulatory and clinical decisions that are grounded in high-quality research and accessible data and results.
  • Strengthen the integrity of research of medical products by ensuring that data is both rigorous and reliable, and by facilitating public access to and independent analysis of clinical trial data and results.
  • Conduct legal, public health and health policy research that identifies strengths and weakness of our existing system for facilitating evidence generation and transparency, and developing and evaluating alternative approaches
  • Provide the public and key policymakers with tools that enhance and facilitate open access to data, research results, and other relevant information about medical products.

Funding

 

Contact Katherine Lawton at CRIT.admin@yale.edu if you are interested in joining our email list 

Contact Us


For more information or to join our mailing list, contact Katherine Lawton, Program Coordinator, at crit.admin@yale.edu or call (203) 436-8420

Mailing Address:

c/o Yale Law School
Collaboration for Research Integrity & Transparency
157 Church Street 17th Floor
New Haven, CT 06510-2100

 

Follow us on Twitter